We’re Proudly Made in America.
With highly automated manufacturing facilities across the country with the production capacity to produce over 4 million tests per month, we are committed to helping people resume their regular activities.
When the pandemic hit and the world shut down, we knew we must respond. Read about the
evolution of the Sal6830 Point of Care PCR System.
Health Canada Authorizes World's First Saliva Point of Care PCR Test to Quickly Detect SARS-CoV-2
Leveraging over $50 million received from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative, MicroGEM pivoted to launch our PCR saliva test for point-of-care detection of SARS-CoV-2.
We rapidly expanded our high-tech manufacturing capacity to over 120,000 square feet of manufacturing space in three different states with production capacity of 4 million COVID-19 tests per month.
Now granted Emergency Use Authorization from the FDA and authorized under Interim Order from Health Canada, the Sal6830 provides 'saliva sample collection to PCR result' at the point of care in under 30 minutes.
Moving the technology from the lab to the point of care is a game changer for molecular diagnostics. Using non-invasive saliva collection where the person being tested gives a sample (saliva) rather than having it taken from them (swab), it provides the speed of a point of care test with the accuracy of a central lab.
The technology brings together MicroGEM’s ultrafast RT-PCR, patented temperature-driven, enzymatic RNA extraction technology, and viral enrichment to quickly, accurately, and comfortably identify people infected with SARS-CoV-2, capturing whole virus as an indicator of infection.
“MicroGEM is committed to help end this devastating pandemic by ensuring high-quality COVID-19 tests are available for more Americans. We’ve leveraged the technologies currently in our pipeline to create a simple and expedient way to provide highly reliable RT-PCR saliva tests to those who need them.”
Jeff Chapman, President and CEOJeff is a global life sciences marketing and business executive possessing strong scientific and technical knowledge in the life sciences industry, developed over 31 years of experience in the Life Sciences and Clinical Diagnostic markets.
LeRoy has more than 35 years of sales experience in the Bioscience, In Vitro Diagnostics (IVD) and Telcom segments, working for brands such as BDH Chemicals, Beckman Instruments, Beckman Coulter, Hewlett Packard, Agilent, Danaher and Horiba.
Brad is a highly experienced human resource leader, successfully leading global HR activities with such brands as Johnson & Johnson, Pentax Medical, AvalonBay, AMB Industries, and The New York Times.
David has over 35 years experience of life science research. His specialties include molecular genetics, microbiology, biotechnology, computational biology and forensic DNA analysis.
Gemma has worked extensively on dynamic projects in governmental, academic, and commercial sectors, Gemma has a proven track record in effective contract drafting, commercial management and negotiation strategy.
Peter has spent 20 years as an executive of two growth companies with experience in investor relations and communication and as an attorney with a corporate transactions, representing life science and industry companies.
Brian is an accomplished chemical engineer and program manager with strong technical knowledge in the fields of cybersecurity, defense, and biotechnology, including the development of polymers for biomolecule separation and purification.
Vinny is a global manufacturing and supply chain executive in the pharmaceutical, diagnostics, and research instrumentation industries. His expertise includes engineering and manufacturing technologies, manufacturing engineering, global supply chain, and quality control.
As a mechanical engineer and a respected quality professional, Tom brings deep experience across a range of therapeutic and diagnostic applications, including MRI, blood management, cell therapy, diabetes care, and optometric care. Tom is a proven strategic leader in product safety, reliability, quality, compliance, and continuous process improvement.
With highly automated manufacturing facilities across the country with the production capacity to produce over 4 million tests per month, we are committed to helping people resume their regular activities.
We're explorers and innovators. We're developing cutting-edge molecular biology technologies for use in the field and at the point of care, where and when they are needed.
From the discovery of microorganisms living in the extreme temperatures of Antarctica, MicroGEM has grown into an international biotechnology company:
Do you have an interest in infectious diseases or molecular biology? Do you want to help develop technologies to improve the health and well-being of people around the world?
Join us!
Say goodbye to columns and beads. MicroGEM’s barrier-breaking single-tube approach speeds up extractions, reduces contamination, significantly decreases manual steps, and minimizes loss of DNA and RNA from precious samples.
Our core competency is the ability to efficiently extract DNA and RNA regardless of the sample size.
For more information on our extraction technologies, associated research products, and online shop, visit www.microgembio.com.
